Dermatomyositis/polymyositis associated with internal malignancy: a consequence of how neoplasms alter generalized...

Area of Science:

• Dermatology
• Immunology
• Oncology

Background:

• The underlying mechanisms driving dermatomyositis/polymyositis (DM/PM) are not fully understood.
• Internal malignancy is a recognized trigger for a subset of DM/PM cases.
• Tumors induce significant alterations in the extracellular matrix (ECM), releasing fractions that enter circulation.

Purpose of the Study:

• To explore the potential role of extracellular matrix (ECM) alterations in the pathogenesis of dermatomyositis/polymyositis (DM/PM).
• To investigate the connection between internal malignancy, ECM changes, and characteristic skin manifestations in DM/PM.
• To hypothesize a unifying mechanism for DM/PM triggers, including malignancy, infections, and drugs.

Main Methods:

• Review of existing literature on DM/PM pathogenesis, ECM composition, and tumor-associated changes.
• Analysis of the proposed mechanism involving circulating ECM fractions and their incorporation into dermal ECM.
• Correlation of proposed ECM alterations with observed skin changes in dermatomyositis (DM), such as mucin formation, edema, and atrophy.

Main Results:

• Internal malignancy triggers DM/PM through alterations in the extracellular matrix (ECM).
• Circulating depolymerized glycosaminoglycans from tumors may be incorporated into the generalized ECM.
• Skin changes in DM, including mucin deposition, edema, and atrophy, are hypothesized to result from these ECM alterations rather than being solely post-inflammatory.

Conclusions:

• The proposed mechanism involving ECM alterations offers a potential explanation for DM/PM triggered by internal malignancy.
• This understanding may elucidate the role of other triggers like infections and drugs in DM/PM.
• The mechanism could also explain other cutaneous signs associated with internal malignancy.